Bod Australia Limited (ASX:BDA) announced yesterday its cannabidiol based cannabis extract will be used in a Post-Traumatic Stress Disorder (PTSD) trial.The extract, MediCabilis 5%...

A systematic review of the efficacy and safety of medical marijuana in migraine treatment has provided some interesting and encouraging results.Migraine affects an estimated...

There were some interesting developments on Australia's cannabusiness scene last week - here's a few highlights. MGC Pharma MGC Pharmaceuticals (ASX:MXC) announced last Tuesday it had...

A study out of Washington State University finds cannabis may provide short term relief of OCD symptoms - but more research needs to be...